• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    BIMI International Medical Inc. Announces Appointment of New Chief Financial Officer

    7/19/21 8:05:00 AM ET
    $YGMZ
    $IFMK
    $BIMI
    Transportation Services
    Consumer Discretionary
    Food Chains
    Consumer Services
    Get the next $YGMZ alert in real time by email

    NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), a leading healthcare products and services provider in China, today announced the appointment of Amy Xue as the Company's new Chief Financial Officer, effective July 15, 2021.

    Xue is a CPA and ACCA certified accountant and experienced senior finance executive. Prior to her appointment as BIMI's Chief Financial Officer, she served as CFO at iFresh, Inc. (NASDAQ:IFMK) between March 2020 and June 2021. She has also served as the CFO of Goldenbridge Acquisition Ltd. since March 2020 and is also the Audit Committee Chairwoman at MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) since September 2020. From July 2018 to March 2020, Xue served as CFO at XT Energy Group, Inc,  in charge of XTEG's communication with SEC, investors and overseeing periodical financial reports. She has also been a partner of Capital Market Accounting Services at Wall Street CPA Services, LLC since November 2010, providing accounting consulting services to public companies listed in US.

    Mr Tiewei Song, Chief Executive Officer and President of the Company, commented: "Ms Xue has a breadth of experience and extensive expertise in capital market transactions and driving efficiencies that will be key for the future of BIMI. Her appointment positions the company strategically for the future as we prepare to take the next steps to drive BIMI's financial growth, which will see the Company solidify its position as a leading provider of healthcare products and services in China."

    About BIMI International Medical Inc.

    BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates two private hospitals in China. For more information, please visit www.usbimi.com.

    Safe Harbor Statement

    Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company's ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company's products and services in the People's Republic of China, general economic conditions and other risk factors detailed in the Company's annual report and other filings with the United States Securities and Exchange Commission.

    Investor Relations Contact:

    Janice Wang

    EverGreen Consulting Inc.

    Email: [email protected]

    Phone: +1 571-464-9470 (from U.S.)                                                                                           

    +86 13811768559 (from China)



    Get the next $YGMZ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $YGMZ
    $IFMK
    $BIMI

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $YGMZ
    $IFMK
    $BIMI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • A Major Contract Awarded to MingZhu

      SHENZHEN, China, March 21, 2025 (GLOBE NEWSWIRE) --  MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (NASDAQ:YGMZ), an elite provider of logistics and transportation services to businesses, today announced Ruoqiang Tengyue Logistics Co., Ltd. ("Ruoqiang Logistics") awarded a major coal transport contract to MingZhu's subsidiary Shenzhen Yangang Mingzhu Supply Chain Management Co. ("Mingzhu Supply Chain"). Under the contract, Mingzhu Supply Chain will provide coal transportation service to Ruoqiang Logistics through March 20, 2030. Ruoqiang Logistics contracted Mingzhu Supply Chain to provide approximately 300 trucks on the route during the contract period. Mr. Jinlong Yan

      3/21/25 9:41:41 AM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary
    • Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

      SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore it no longer complies with the Nasdaq Listing Rule 5550(a)(2) (the "Rule

      2/14/25 4:00:00 PM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary
    • Mingzhu Announces Unaudited Financial Results for the Six Months Ended June 30, 2024

      SHENZHEN, China, Dec. 31, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (NASDAQ:YGMZ), an elite provider of logistics and transportation services to businesses, today announced its unaudited financial results for the six months ended June 30, 2024. Mr. Jinlong Yang, CEO of MingZhu, commented, "After the severe negative impact of the COVID downturn, our focus has been on rebuilding our core logistics business. This process has demanded substantial resources, including significant investments and dedicated personnel to meet customer needs. Unfortunately, the additional costs, coupled with higher interest rates, have been amplified by lower sales during t

      12/31/24 4:00:00 PM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary

    $YGMZ
    $IFMK
    $BIMI
    Leadership Updates

    Live Leadership Updates

    See more
    • BIMI Announces Results of 2023 Annual General Meeting of Stockholders

      New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company's 2022 Annual General Meeting of Stockholders (the "Annual Meeting") held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022. At the Annual General Meeting the shareholders voted and approved; 1. The election of seven directors to serve on the board of directors of the Company, until the next annual meeting of Stockholders and until their respective successors have been duly elected and quali

      1/3/24 7:00:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor

      NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI, "BIMI"))), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company ("Hao Mu"), as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements in Hong Kong, Taiwan and Macau. Pursuant to the terms of a sales agreement entered into on October 29, 2023, Hao Mu must make annual purchases of at least $5 million in order to maintain its exclusive distributor status for this territory. Under the terms of this agreement, Phenix's comprehensive portfolio of high-quality herbal su

      10/30/23 9:29:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor

      NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI, "BIMI"))), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company ("Hao Mu"), as a distributor responsible for the distribution of Phenix's 17 herbal supplements in Mainland China. Pursuant to the terms of a sales agreement entered into on October 29, 2023, Hao Mu must make annual purchases of at least $5 million in order to maintain its distributor status for this territory. Under the terms of this agreement, Phenix's comprehensive portfolio of high-quality herbal supplements will be made available to co

      10/30/23 9:27:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $YGMZ
    $IFMK
    $BIMI
    SEC Filings

    See more
    • SEC Form NT 20-F filed by MingZhu Logistics Holdings Limited

      NT 20-F - MingZhu Logistics Holdings Ltd (0001782037) (Filer)

      5/1/25 12:30:21 PM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary
    • SEC Form 6-K filed by MingZhu Logistics Holdings Limited

      6-K - MingZhu Logistics Holdings Ltd (0001782037) (Filer)

      4/22/25 4:05:01 PM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary
    • SEC Form 6-K filed by MingZhu Logistics Holdings Limited

      6-K - MingZhu Logistics Holdings Ltd (0001782037) (Filer)

      4/2/25 4:05:11 PM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary

    $YGMZ
    $IFMK
    $BIMI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by BIMI International Medical Inc. (Amendment)

      SC 13D/A - BIMI Holdings Inc. (0001213660) (Subject)

      1/11/24 4:46:28 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13D/A filed by BIMI International Medical Inc. (Amendment)

      SC 13D/A - BIMI International Medical Inc. (0001213660) (Subject)

      12/19/23 4:01:04 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13D filed by BIMI International Medical Inc.

      SC 13D - BIMI International Medical Inc. (0001213660) (Subject)

      8/8/22 4:45:19 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $YGMZ
    $IFMK
    $BIMI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)

      4 - BIMI Holdings Inc. (0001213660) (Issuer)

      6/13/24 1:06:18 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • New insider Smith Symington Wei claimed ownership of 3,456 shares (SEC Form 3)

      3 - BIMI Holdings Inc. (0001213660) (Issuer)

      3/20/24 8:04:41 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • Tiewei Song sold $2,903 worth of shares (724 units at $4.01), decreasing direct ownership by 0.21% to 341,117 units (SEC Form 4)

      4 - BIMI Holdings Inc. (0001213660) (Issuer)

      3/4/24 4:03:12 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $YGMZ
    $IFMK
    $BIMI
    Financials

    Live finance-specific insights

    See more
    • MingZhu Logistics to Acquire HOLDCO 36 in Transformational Business Combination

      SHENZHEN, China, Sept. 12, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (NASDAQ:YGMZ), an elite provider of logistics and transportation services to businesses, today announced the acquisition of HOLDCO 36 in a transformational business combination. The closing of the all-stock acquisition is subject to customary closing conditions, including regulatory approvals. Mr. Jinlong Yang, Chairman and Chief Executive Officer of MingZhu, commented, "As part of our active M&A process, we have evaluated a series of potential transactions, with regard to long-term potential, valuation, and alignment with building shareholder value. We are excited about the propo

      9/12/24 9:07:00 AM ET
      $YGMZ
      Transportation Services
      Consumer Discretionary
    • BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results

      NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months and nine months ended September 30, 2023. Revenues for the three months ended September 30, 2023 and 2022 were $2,523,193 and $4,932,479, respectively. Revenues for the nine months ended September 30, 2023 and 2022 were $11,278,496 and $10,476,224, respectively. The revenues of the Zhongshan, Qiangsheng, Eurasia, and Minkang hospitals, that are held for sale, were accounted for separately. Net loss for the three months ended September 30, 2023 and 2022 was $3,134,072 and $3,099,662, respectively, whi

      12/19/23 8:01:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

      NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023. The Company reported a significant increase in gross margin underlining the ongoing success of its business strategy and operational effectiveness. Revenues for the six months ended June 30, 2023 and 2022 were $8,755,303 and $5,543,745, respectively. Compared with the same period in 2022, revenue increased by $3,211,558, due to the inclusion of the revenues of Phenix Bio Inc., which was acquired on March 15, 2023. The revenues of the Zhongshan, Qiangsheng, Eurasia, and Minkang h

      11/27/23 8:25:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care